United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - hypromellose - eye drops - 3mg/1ml

United States - English - NLM (National Library of Medicine)

hi-healthcare inc - hypromelloses     0.2% polysorbate 80     0.5% naphazoline hydrochloride     0.025% zinc sulfate     0.25% - hypromelloses      lubricant polysorbate 80      lubricant naphazoline hydrochloride      redness reliever zinc sulfate       astringent - for the temporary relief of discomfort and redness of the eye due to minor eye irritations. - for the temporary relief of burning & irritation due to dryness of the eye. - for protection against further irritation. • eye pain. • changes in vision. • continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

Kenya - English - Pharmacy and Poisons Board

aurolab sivagangai main road veerapanjan madurai 625 020 - hypromellose usp 2% w/v sterile solution - eye drops - hypromellose usp 2% w/v sterile solution - other ophthalmologicals

Malta - English - Medicines Authority

novartis ireland limited - dextran 70; hypromellose - eye drops, solution - dextran 70 1 mg/ml; hypromellose 3 mg/ml - ophthalmologicals

United States - English - NLM (National Library of Medicine)

aurolab - hypromellose 2910 (4000 mpa.s) (unii: rn3152op35) (hypromellose 2910 (4000 mpa.s) - unii:rn3152op35) - - for use as a lubricant to prevent further irritation or to relieve dryness of the eye - if you are sensitive to any ingredient in this product - if solution changes color or becomes cloudy for use as a lubricant to prevent further irritaion or to relieve dryness of the eye

United States - English - NLM (National Library of Medicine)

covalent medical - hypromellose 2910 (4000 mpa.s) (unii: rn3152op35) (hypromellose 2910 (4000 mpa.s) - unii:rn3152op35) - - for use as a lubricant to prevent further irritation or to relieve dryness of the eye - if you are sensitive to any ingredient in this product - if solution changes color or becomes cloudy for use as a lubricant to prevent further irritaion or to relieve dryness of the eye

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - dexamethasone, quantity: 1 mg/ml - eye drops, suspension - excipient ingredients: dibasic sodium phosphate; polysorbate 80; disodium edetate; sodium chloride; benzalkonium chloride; purified water; hypromellose; citric acid monohydrate; sodium hydroxide - indications as at 16 jan 2005 : steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe, such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitis when the inherent hazard of steroid use is accepted to obtain an advisable diminution in oedema and inflammation; acute and chronic anterior uveitis; corneal injury from chemical radiation or thermal burns or penetration of foreign bodies.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - pilocarpine hydrochloride, quantity: 40 mg/ml - eye drops, solution - excipient ingredients: boric acid; sodium citrate dihydrate; purified water; benzalkonium chloride; hypromellose - in the treatment of glaucoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - pilocarpine hydrochloride, quantity: 20 mg/ml - eye drops, solution - excipient ingredients: sodium citrate dihydrate; purified water; boric acid; hypromellose; benzalkonium chloride - in the treatment of glaucoma.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - pilocarpine hydrochloride, quantity: 10 mg/ml - eye drops, solution - excipient ingredients: sodium citrate dihydrate; boric acid; hypromellose; purified water; sodium chloride; benzalkonium chloride - in the treatement of glaucoma.